ECO Animal Health Group (EAH) Share Price, News & Analysis

Company Overview

ECO Animal Health is a world leader in animal health, developing and marketing branded veterinary pharmaceuticals globally, with expertise in antibiotics and vaccines for pigs and poultry. We have a maturing proprietary R&D pipeline. Headquartered in the UK, with global offices including R&D and manufacturing, we have marketing authorisations in over 70 countries and employ over 200 people worldwide. Our lead product, Aivlosin® is a proprietary, patented medication which is effective against both respiratory and intestinal diseases in pigs and poultry.

Key Stats

• Today's Range: 82 to 83.84
• 50-Day Range: 72.04 to 99.85
• 52-Week Range: 50 to 100
• Volume: 62,011 shs
• Average Volume: 88,994 shs
• Market Capitalization: £55.80 million
• P/E Ratio: 34.02
• Dividend Yield: 0.94%
• Price Target: GBX 150
• Consensus Rating: Buy

ECO Animal Health Group Stock Analysis - MarketRank™

ECO Animal Health Group scored higher than 52% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.7 / 5
• Analyst Rating: Buy

Consensus Rating

ECO Animal Health Group has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

Upside Potential

ECO Animal Health Group has a consensus price target of GBX 150, representing about 81.4% upside from its current price of GBX 82.68.

Amount of Analyst Coverage

ECO Animal Health Group has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of ECO Animal Health Group is 34.02, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 82.64.

Price to Earnings Ratio vs. Sector

The P/E ratio of ECO Animal Health Group is 34.02, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 29.67.

Price to Book Value per Share Ratio

ECO Animal Health Group has a P/B Ratio of 0.60. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for EAH.

Dividend

• Score: 0.0 / 5
• Dividend Strength: Weak

Dividend Yield

ECO Animal Health Group has a dividend yield of 0.94%, which is in the bottom 25% of all stocks that pay dividends.

Dividend Growth

ECO Animal Health Group does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Short Interest

There is no current short interest data available for EAH.

News and Social Media

• Score: 1.9 / 5
• News Sentiment: 0.42

News Sentiment

ECO Animal Health Group has a news sentiment score of 0.42. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.57 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 3 news articles for ECO Animal Health Group this week, compared to 0 articles on an average week.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, ECO Animal Health Group insiders have not sold or bought any company stock.

Percentage Held by Insiders

11.03% of the stock of ECO Animal Health Group is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

46.26% of the stock of ECO Animal Health Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

EAH Stock Analysis - Frequently Asked Questions

How have EAH shares performed this year?

ECO Animal Health Group's stock was trading at GBX 67 on January 1st, 2025. Since then, EAH stock has increased by 23.4% and is now trading at GBX 82.68.

How were ECO Animal Health Group's earnings last quarter?

ECO Animal Health Group plc (LON:EAH) posted its quarterly earnings data on Monday, July, 14th. The company reported $2.49 earnings per share for the quarter. ECO Animal Health Group had a net margin of 1.17% and a trailing twelve-month return on equity of 1.27%.

How do I buy shares of ECO Animal Health Group?

Shares of EAH stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What other stocks do shareholders of ECO Animal Health Group own?

Based on aggregate information from My MarketBeat watchlists, some other companies that ECO Animal Health Group investors own include Intrepid Potash (IPI), Allena Pharmaceuticals (ALNA), Anpario (ANP), Iovance Biotherapeutics (IOVA), Navios Maritime (NM), Ampliphi Biosciences (APHB) and Actinium Pharmaceuticals (ATNM).

Company Calendar

• Last Earnings: 7/14/2025
• Today: 10/23/2025

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: N/A
• Current Symbol: LON:EAH
• CIK: N/A
• Web: www.ecoanimalhealthgroupplc.com
• Phone: +44-20-83362900
• Fax: N/A
• Employees: 234
• Year Founded: N/A

Price Target and Rating

• Average Price Target for ECO Animal Health Group: GBX 150
• High Price Target: GBX 150
• Low Price Target: GBX 150
• Potential Upside/Downside: +81.4%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 1 Analysts

Profitability

• EPS (Trailing Twelve Months): GBX 2.43
• Trailing P/E Ratio: 34.02
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: £1.05 million
• Net Margins: 1.17%
• Pretax Margin: N/A
• Return on Equity: 1.27%
• Return on Assets: 2.14%

Debt

• Debt-to-Equity Ratio: 4.81
• Current Ratio: 2.96
• Quick Ratio: 2.14

Sales & Book Value

• Annual Sales: £79.60 million
• Price / Sales: 0.70
• Cash Flow: GBX 13.66 per share
• Price / Cash Flow: 6.05
• Book Value: GBX 137.84 per share
• Price / Book: 0.60

Miscellaneous

• Outstanding Shares: 67,490,000
• Free Float: N/A
• Market Cap: £55.80 million
• Optionable: Not Optionable
• Beta: -0.05